Regenerative Medicine and Stem Cells Technologies

3 stem cell and regenerative medicine projects unveiled; Sattari: "Gene therapy" is used to treat incurable diseases in the country and a specialized primary hospital for people is set up.

The center, located at the Royan Research Institute, is a bridge between the laboratory and preclinical stages of developing stem cell-based products and reconstructive medicine until it reaches the therapeutic stage and the industrial production of a large-scale product. Knowledge-based companies and startups are established in this center and use its services to develop products in this field. Therefore, strong scientific infrastructure for the development of products based on reconstructive medicine is provided in order to implement the production and quality control of cell therapy, gene therapy and tissue engineering products, as well as quality assurance of related products.

Establishing knowledge-based companies in the Royan collection is essential

Sorena Sattari, Vice President for Science and Technology, attended the Royan Research Institute and unveiled three preclinical projects of the center, referring to the position of the Royan Research Complex in the country, said: "This complex has an important role in ecological development of stem cells and reconstructive medicine." Always at the forefront of basic research.

The Vice President for Science and Technology continued: "This collection is a monument to Kazem Ashtiani and prominent researchers are working in it." I am glad to see that the discussion of gene therapy is being seriously pursued in the country for the treatment of cancer and in this collection.

The head of the National Elite Foundation also said: "This complex was once a leader in the field of cell therapy and today it has entered the discussion of gene therapy." We hope to receive market approval for their product within the next year. This is a big event in the field of clinical research on the frontier of knowledge.

Sattari, stating that every time I visit the Royan research complex, I see a new project and event, said: "It is a very good event that this collection works dynamically and gradually moves towards the creation of knowledge-based companies so that it can Provide a significant portion of the revenue and funding for basic research. This self-reliance will be a strong point in the future of the embryo.

The Vice President for Science and Technology, referring to the support of the Vice President for Science and Technology for the activities of this group, said: A campus will be created. This complex is the first specialized hospital for primary care in the region. This group works in various fields of cognitive sciences, biomedicines and vaccines, etc.

The Vice President for Science and Technology also stated: The money of the private sector is effective in the field of research. Research is done with government money; But it does not work. We have to use private power and money to do applied research.

Also, Hamid Reza Taybi, the head of the University Jihad, said at the ceremony: "One of the problems of the Royan collection goes back to the field of first contracts, which usually no one or no one accepts the risk of." We ask Dr. Sattari to solve this problem. According to him, we are trying to pave the way for the establishment of knowledge-based companies in our field of activity, in order to prepare the ground for the pervasiveness of the knowledge-based economy in the country. With the support of the Vice President for Science and Technology and the National Development Fund, we accelerated the financing of our projects.

The future of cancer has shifted to immune cell therapy Amir Ali Hamidieh, Secretary of the Stem Cell Science and Technology Development Headquarters, also said at the ceremony: "The future of cancer treatment will move towards treatment with immune cells instead of chemotherapy and radiotherapy." There are different types of these cells, some of which can be used to treat cancer. He added: "In us, cancer with immune cells is one of the new scientific methods in the world." This is a very complex and difficult project that has received a lot of attention in the world.

Hamidiyeh continued: "Cancer is one of the problems of the health system in the world and still in more than half of the cases, malignant tumors do not respond properly to the usual treatments in this field, but we hope to bring this disease one step closer to treatment with immune cells."

He also said: "In this treatment model, immune cells go to war with cancer cells to speed up the definitive treatment of this disease."

3 completed projects were unveiled in 1999 by Royan Research Institute. Projects carried out by university jihad researchers have raised hopes for the cure of diseases in the country. Among these projects, we can mention the project of using immune cells in the treatment of cancer, which in collaboration with Tehran University of Medical Sciences has been conducted a clinical trial on 5 patients with malignant brain tumors.

The production of Covida transgenic mice, which can be tested to evaluate the results of effective drugs and vaccines in the treatment of coronary artery, is another project in this series. The production of cell and gene therapy products for the treatment of cancer patients and the efficient product 19 that helps treat cancer was another product that was unveiled.